FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.49), $0.20 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $0 , versus $0 reported last year.
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
... More
